Recessive TMOD1 mutation causes childhood cardiomyopathy.
Catalina VasilescuMert ColpanTiina H OjalaTuula ManninenAino MutkaKaisa YlänenOtto RahkonenTuija PoutanenLaura MarteliusReena KumariHelena HinterdingVirginia BrilhanteSimo OjanenPekka LappalainenJuha KoskenvuoChristopher J CarrollVelia M FowlerCarol C GregorioAnu SuomalainenPublished in: Communications biology (2024)
Familial cardiomyopathy in pediatric stages is a poorly understood presentation of heart disease in children that is attributed to pathogenic mutations. Through exome sequencing, we report a homozygous variant in tropomodulin 1 (TMOD1; c.565C>T, p.R189W) in three individuals from two unrelated families with childhood-onset dilated and restrictive cardiomyopathy. To decipher the mechanism of pathogenicity of the R189W mutation in TMOD1, we utilized a wide array of methods, including protein analyses, biochemistry and cultured cardiomyocytes. Structural modeling revealed potential defects in the local folding of TMOD1 R189W and its affinity for actin. Cardiomyocytes expressing GFP-TMOD1 R189W demonstrated longer thin filaments than GFP-TMOD1 wt -expressing cells, resulting in compromised filament length regulation. Furthermore, TMOD1 R189W showed weakened activity in capping actin filament pointed ends, providing direct evidence for the variant's effect on actin filament length regulation. Our data indicate that the p.R189W variant in TMOD1 has altered biochemical properties and reveals a unique mechanism for childhood-onset cardiomyopathy.
Keyphrases
- heart failure
- single cell
- early life
- young adults
- endothelial cells
- pulmonary hypertension
- staphylococcus aureus
- gene expression
- single molecule
- pseudomonas aeruginosa
- high throughput
- case report
- molecular dynamics simulations
- big data
- autism spectrum disorder
- binding protein
- copy number
- amino acid
- genome wide
- cell proliferation
- pi k akt